Home Stock

Stock Research: Embla Medical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Embla Medical

CPH:EMBLA IS0000000040
72
  • Value
    23
  • Growth
    39
  • Safety
    Safety
    90
  • Combined
    46
  • Sentiment
    84
  • 360° View
    360° View
    72
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Embla Medical hf, formerly Ossur hf, develops and distributes medical equipment and supplies. It operates in non-invasive prosthetics, medical braces, and supports. Based in Iceland, they have clinics worldwide. In the last fiscal year, the company had a market cap of $2,161 million, profits of $535 million, and revenue of $855 million, with 4078 employees.

more

ANALYSIS: With an Obermatt 360° View of 72 (better than 72% compared with alternatives), overall professional sentiment and financial characteristics for the stock Embla Medical are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Embla Medical. The consolidated Sentiment Rank has a good rank of 84, which means that professional investors are more optimistic about the stock than for 84% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 90 or better than 90% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 23, meaning that the share price of Embla Medical is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 39. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Safety
Country Iceland
Industry Health Care Equipment
Size Medium
Website emblamedical.com
Index
Embla Medical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 30 43 45
Growth
39 68 69 87
Safety
Safety
90 38 16 15
Sentiment
84 50 61 48
360° View
360° View
72 35 44 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
41 67 40 81
Opinions Change
50 8 50 50
Pro Holdings
n/a 6 6 6
Market Pulse
83 85 88 56
Sentiment
84 50 61 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
23 30 43 45
Growth
39 68 69 87
Safety Safety
90 38 16 15
Combined
46 24 25 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
42 49 56 55
Price vs. Earnings (P/E)
45 42 44 35
Price vs. Book (P/B)
58 54 58 50
Dividend Yield
1 1 1 1
Value
23 30 43 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
82 64 56 52
Profit Growth
52 54 80 100
Capital Growth
23 76 67 98
Stock Returns
18 56 39 29
Growth
39 68 69 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
67 32 32 28
Refinancing
82 43 37 31
Liquidity
79 48 31 28
Safety Safety
90 38 16 15

Similar Stocks

Discover high‑ranked alternatives to Embla Medical and broaden your portfolio horizons.

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Jupiter

LSE:JUP
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Costain

LSE:COST
Country: United Kingdom
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Star Bulk Crirs

NSQ:SBLK
Country: Greece
Industry: Marine
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews